Navigation Links
aTyr Pharma to Present at Japan Biopharma Partnering Conference
Date:9/24/2009

SAN DIEGO, Calif., Sept. 24 /PRNewswire/ -- aTyr Pharma, Inc., a biopharmaceutical company discovering and developing a new class of naturally occurring proteins as biotherapeutics, will present at the Japan Biopharma Conference in Tokyo on Tuesday October 6. Jeff Watkins, CEO of aTyr Pharma, will provide an overview of aTyr Pharma's technology, product engine, and lead program based on naturally occurring resected proteins of the tRNA synthetases. The aminoacyl tRNA synthetases are universal and essential elements of the protein synthesis machinery found in all organisms, but human synthetases and their associated proteins have naturally occurring resected variants, called "resectins," with potent cell signaling activities that are vital to normal functioning of humans. The resectins' activities are distinct from the protein synthesis activities commonly known for synthetases, and aTyr Pharma is discovering and developing the resectins as new biotherapeutic agents that can be used to treat a wide variety of human diseases including inflammatory, autoimmune, hematopoietic and metabolic disorders.

According to Cheryl Quinn, Director of Business Development at aTyr Pharma, "Our broad multi-asset portfolio of novel biotherapeutics can help pharmaceutical companies rapidly build out their biologics pipeline. We look forward to taking part in the Japan Biopharma conference, as well as meeting potential partners from Japan and Asia and to explore mutually beneficial opportunities."

About aTyr Pharma

aTyr Pharma, Inc. is a biopharmaceutical company focused on the discovery and development of an entirely new class of biologics. aTyr Pharma's discovery engine for new biotherapeutics consists of novel proteins in the family of tRNA synthetases with cell signaling activities distinct from the protein synthesis activities commonly associated with the tRNA synthetases. These resected proteins, or "resectins," are being developed as novel therapeutics to treat hematological disorders, neurodegenerative diseases, inflammation, cardiovascular diseases and metabolic disorders.

www.atyrpharma.com


'/>"/>
SOURCE aTyr Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. QRxPharma Announces Strategic Alliance with Liaoning Nuokang Medicines Co Ltd for the Development of Venomics Assets
2. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of Directors
3. Kaiser Permanente Recognized by J.D. Power and Associates as Highest in Customer Satisfaction Among Mail-Order Pharmacies
4. Cambridge Healthtech Institute and Bio-IT World Launch a New eNewsletter: Pharma Services News
5. PharmAthene to Present at The Maxim Group Growth Conference September 29, 2009
6. Pharmaceutical, Biotech Research Companies Support Newark Rx Assistance Program
7. Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing, 3rd Edition Report
8. Cardinal Health Introduces Expanded Suite of Services to Help Hospital Pharmacies Improve Cost Containment, Workflow, Patient Safety
9. Biostar Pharmaceuticals, Inc. to Present at the Maxim Group Growth Conference on September 29 at 2:00pm ET
10. Baxa IntelliFlowRx(TM) Upgrades Expand Pharmacy Capabilities
11. DUSA Pharmaceuticals to Present at the Maxim Group 3rd Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... Natalie Jill ... local company MitoXcell in preparation of the launch of her new book: Natalie Jill’s ... is a nutritional guide designed to jump start a new healthy lifestyle featuring simple ...
(Date:5/4/2016)... Durham, NC (PRWEB) , ... May 04, 2016 ... ... healthcare professionals in medical coding, billing and compliance. In upcoming months, AudioEducator has ... on various specialties. Every conference is designed to give complete compliance know-how and ...
(Date:5/4/2016)... Los Angeles, California (PRWEB) , ... May 04, 2016 , ... ... for Cancer Research (AACR) honors the month of May as National Cancer Research Month. ... to 1.6 million new diagnoses of cancer with predications of one in four Americans ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... that their Vasont Universal Integrator (VUI) extension supports the latest release of Adobe ... Adobe FrameMaker 2015 interlace the process of creating, editing and storing XML. ...
(Date:5/3/2016)... ... 2016 , ... ProIntro Glitch is a set of 30 self-animating glitch-themed intros ... users to add a terrifying opener to any video or media. Choose from unique ... add greater contrast, all the user has to do is increase the turn on ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... In March, 2016, Rx-360 ... free workshops across Africa ... Good Distribution Practices (GDP). Good Distribution Practice is ... are consistently stored, transported and handled under suitable conditions as ... Only a few years ago, there were few ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Multiple Myeloma Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Competitive Landscape Highlights 2016, provides comprehensive insights ... epidemiology, Multiple Myeloma market valuations and forecast, ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Myeloid Leukemia ...  report to their offering.       ... Acute Myeloid Leukemia Market and Competitive Landscape ... Myeloid Leukemia pipeline products, Acute Myeloid Leukemia ...
Breaking Medicine Technology: